Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet


Por: Dohner, H, Estey, EH, Amadori, S, Appelbaum, FR, Buchner, T, Burnett, AK, Dombret, H, Fenaux, P, Grimwade, D, Larson, RA, Lo-Coco, F, Naoe, T, Niederwieser, D, Ossenkoppele, GJ, Sanz, MA, Sierra, J, Tallman, MS, Lowenberg, B, Bloomfield, CD

Publicada: 21 ene 2010
Resumen:
In 2003, an international working group last reported on recommendations for diagnosis, response assessment, and treatment outcomes in acute myeloid leukemia (AML). Since that time, considerable progress has been made in elucidating the molecular pathogenesis of the disease that has resulted in the identification of new diagnostic and prognostic markers. Furthermore, therapies are now being developed that target disease-associated molecular defects. Recent developments prompted an international expert panel to provide updated evidence- and expert opinion-based recommendations for the diagnosis and management of AML, that contain both minimal requirements for general practice as well as standards for clinical trials. A new standardized reporting system for correlation of cytogenetic and molecular genetic data with clinical data is proposed. (Blood. 2010; 115: 453-474)

Filiaciones:
Dohner, H:
 Univ Ulm, Dept Internal Med 3, D-89081 Ulm, Germany

Estey, EH:
 Seattle Canc Ctr Alliance, Seattle, WA USA

Amadori, S:
 Tor Vergata Univ Hosp, Dept Hematol, Rome, Italy

Appelbaum, FR:
 Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA

Buchner, T:
 Univ Munster, Dept Hematol Oncol, Munster, Germany

Burnett, AK:
 Cardiff Univ, Dept Haematol, Cardiff CF4 4XN, S Glam, Wales

Dombret, H:
 Hop St Louis, AP HP, Inst Univ Hematol, Paris, France

Fenaux, P:
 Hop Avicenne, Serv Hematol Clin, F-93009 Bobigny, France

Grimwade, D:
 Guys Kings & St Thomas Sch Med, Dept Med & Mol Genet, London, England

Larson, RA:
 Univ Chicago, Dept Med, Chicago, IL 60637 USA

 Univ Chicago, Canc Res Ctr, Chicago, IL 60637 USA

Lo-Coco, F:
 Univ Tor Vergata, Dept Biopathol, Rome, Italy

 Ctr Europeo Ric Cervello, Santa Lucia Fdn, Rome, Italy

Naoe, T:
 Nagoya Univ Hosp, Dept Hematol, Showa Ku, Nagoya, Aichi, Japan

Niederwieser, D:
 Univ Leipzig, Dept Hematol Oncol & Hemostasis, Leipzig, Germany

Ossenkoppele, GJ:
 Vrije Univ Amsterdam, Med Ctr, Dept Haematol, Amsterdam, Netherlands

Sanz, MA:
 Univ Hosp La Fe, Hematol & Bone Marrow Transplant Unit, Valencia, Spain

Sierra, J:
 Hosp Santa Creu & Sant Pau, Dept Clin Hematol, Barcelona, Spain

Tallman, MS:
 Northwestern Univ, Div Hematol Oncol, Feinberg Sch Med, Chicago, IL 60611 USA

Lowenberg, B:
 Erasmus Univ, Med Ctr, Dept Hematol, Rotterdam, Netherlands

Bloomfield, CD:
 Ohio State Univ, Ctr Comprehens Canc, Arthur G James Canc Hosp, Columbus, OH 43210 USA
ISSN: 00064971





BLOOD
Editorial
AMER SOC HEMATOLOGY, 2021 L ST NW, SUITE 900, WASHINGTON, DC 20036 USA, Estados Unidos America
Tipo de documento: Review
Volumen: 115 Número: 3
Páginas: 453-474
WOS Id: 000273820600006
ID de PubMed: 19880497

MÉTRICAS